Resveratrol: What It Actually Does for Blood Pressure and Blood Sugar

A close look at what the research says about resveratrol, from red wine buzzword to studied compound for insulin sensitivity and blood pressure.

Track the foods that fit your goals. Track it free with Ration →

By the Ration Editorial Team · Reviewed against primary research · Updated July 14, 2026

Resveratrol is a polyphenol, a type of plant compound that acts as an antioxidant.

It is best known for its presence in red wine, but it also shows up in grape skins, blueberries, cranberries, and peanuts.

Interest in resveratrol exploded after researchers noticed it might explain part of the so called French paradox, the observation that French populations have relatively low rates of heart disease despite diets rich in saturated fat^[11].

Since then, it has become one of the most studied polyphenols for metabolic and cardiovascular health^[4].

Resveratrol is often described as an activator of SIRT1, a protein involved in cellular energy regulation and aging pathways.

SIRT1 has earned a reputation as a longevity related gene because it influences how cells respond to stress, inflammation, and metabolic signals^[1].

Laboratory studies suggest resveratrol like compounds can directly activate SIRT1^[5], and some research has explored this pathway in contexts ranging from cognitive function^[12] to oocyte aging^[6].

Beyond SIRT1, resveratrol also appears to influence blood vessel function and gut microbiota composition, two mechanisms that may explain its effects on blood pressure and insulin sensitivity^[2][10].

This is where the evidence for resveratrol is strongest.

A randomized controlled trial in adults with obesity and insulin resistance found that resveratrol supplementation shifted gut microbiota composition alongside improvements in insulin sensitivity and lipid metabolism^[2].

In people with type 2 diabetes, another placebo controlled trial reported improvements in glucose regulation, along with reductions in inflammation and oxidative stress markers^[3].

Taken together, six sources in our database converge on a consistent direction of effect for insulin sensitivity, earning this outcome the highest evidence grade in our review.

Blood pressure is the other outcome with a substantial body of evidence behind it.

A 2019 meta-analysis of randomized controlled trials found that resveratrol supplementation was associated with reductions in blood pressure, though effects varied by dose and study population^[9].

A separate systematic review focused specifically on people with cardiovascular disorders and found that both dose and duration of treatment influenced whether blood pressure improvements were seen, with higher doses and longer trials generally showing more consistent effects^[7].

In people with type 2 diabetes on glucose lowering medication, a meta-analysis found resveratrol supplementation was linked to improvements in blood pressure and some markers of kidney function^[8].

Mechanistically, this tracks with research showing resveratrol supports healthy blood vessel function, including effects on arterial stiffness and endothelial signaling^[10].

Here is how the research stacks up across the three most studied outcomes for resveratrol.

• ↓Systolic Blood PressureAHuman trials

  Research may lower Systolic Blood Pressure · strong agreement · 6 studies

  View 5 studies on PubMed

  • Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials (2015)
  • Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials (2019)
  • The Effect of Resveratrol dose and Duration of Treatment on Blood Pressure in Patients with Cardiovascular Disorders: A Systematic Review (2020)
  • A Meta-Analysis of the Impact of Resveratrol Supplementation on Markers of Renal Function and Blood Pressure in Type 2 Diabetic Patients on Hypoglycemic Therapy (2020)
  • Resveratrol and Its Effects on the Vascular System (2019)
• ↑Insulin SensitivityAHuman trials

  Research may raise Insulin Sensitivity · strong agreement · 6 studies

  View 5 studies on PubMed

  • Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials (2014)
  • Supplementation with resveratrol modified gut microbiota improving insulin sensitivity and lipid metabolism in subjects with obesity and insulin resistance (2025)
  • Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial (2022)
  • Red Wine Consumption and Cardiovascular Health (2019)
  • Mitochondrial biogenesis: pharmacological approaches (2014)
• ↑SIRT1DPreliminary

  Research may raise SIRT1 · strong agreement · 6 studies

  View 5 studies on PubMed

  • Resveratrol Boosts Cognitive Function by Targeting SIRT1 (2018)
  • Interaction between resveratrol and SIRT1: role in neurodegenerative diseases (2025)
  • Resveratrol-like Compounds as SIRT1 Activators (2022)
  • The effects of resveratrol and SIRT1 activation on dystrophic cardiomyopathy (2015)
  • Resveratrol and SIRT1: Antiaging Cornerstones for Oocytes? (2022)

Notice the gap between insulin sensitivity and blood pressure, both grade A with six sources each, and SIRT1 activation, which sits at grade D despite being resveratrol's most famous mechanism.

This gap matters. Much of the SIRT1 story comes from cell and animal research^{[1][5][6][12]}, while direct human evidence that resveratrol reliably activates SIRT1 at achievable doses remains thin.

• Red and purple grape skins
• Red wine, in modest amounts
• Blueberries and cranberries
• Peanuts and peanut butter
• Pistachios
• Cocoa and dark chocolate, in smaller amounts

Dietary amounts of resveratrol are generally far lower than the doses used in clinical trials, which is part of why supplement forms exist^[4].

Clinical trials investigating resveratrol have used a wide range of doses, often between roughly 150 mg and 1000 mg per day, with some studies going higher^[7][9].

The systematic review on blood pressure found that both dose and duration influenced outcomes, suggesting that very short trials or very low doses may not show measurable effects^[7].

Reported side effects across trials have generally been mild, including occasional gastrointestinal discomfort, though long term safety data at high supplemental doses in humans is still limited^[3][8].

People taking blood pressure medication or glucose lowering drugs should be aware that resveratrol's effects on these same pathways could theoretically compound with their treatment^[8].

• Adults with insulin resistance or type 2 diabetes exploring adjunct approaches to metabolic health^[2][3]
• People interested in cardiovascular support, given its studied effects on blood pressure and vascular function^[9][10]
• Researchers and biohackers curious about SIRT1 and cellular aging pathways, with the caveat that human evidence here is still emerging^[1][5]

Resveratrol has some of the better clinical trial support among popular polyphenols, particularly for insulin sensitivity and blood pressure^[2][3][7][9].

Its reputation as a SIRT1 activating longevity compound is scientifically interesting but rests mostly on laboratory and mechanistic research rather than strong human trial data^[1][5][6].

Anyone considering resveratrol, especially alongside blood pressure or diabetes medication, should treat it as a supplement to discuss with a healthcare provider rather than a proven treatment on its own.